{{Cite journal| doi = 10.1186/s13063-020-04678-4| issn = 1745-6215 (Electronic) 1745-6215 (Linking)| volume = 21| issue = 1| pages = 770| last1 = Barco| first1 = S.| last2 = Bingisser| first2 = R.| last3 = Colucci| first3 = G.| last4 = Frenk| first4 = A.| last5 = Gerber| first5 = B.| last6 = Held| first6 = U.| last7 = Mach| first7 = F.| last8 = Mazzolai| first8 = L.| last9 = Righini| first9 = M.| last10 = Rosemann| first10 = T.| last11 = Sebastian| first11 = T.| last12 = Spescha| first12 = R.| last13 = Stortecky| first13 = S.| last14 = Windecker| first14 = S.| last15 = Kucher| first15 = N.| title = Enoxaparin for primary thromboprophylaxis in ambulatory patients with coronavirus disease-2019 (the OVID study): a structured summary of a study protocol for a randomized controlled trial| journal = Trials| date = 2020-09-11| pmid = 32907635}}